Restoring a Normal T Cell Receptor Repertoire Using the Xcellerate™ Technology: A Potential Therapeutic Strategy for Patients with Hematological Disorders and Autoimmune Diseases.

Alice Long, Mark Bonyhadi(Thermo Fisher Scientific (Norway)), Joy Lawrence(Massachusetts Department of Public Health), Ronald Berenson(University of Freiburg), Jahan S. Khalili
Blood
November 16, 2004
Cited by 0


Related Papers